Hims & Hers is a US telehealth platform, founded in 2017 and listed on the NYSE, connecting consumers with licensed providers for prescriptions, OTC medications, lab testing, and ongoing care.
Hims & Hers is a health and wellness telehealth platform founded in 2017 that connects consumers with licensed healthcare providers for personalized care. Through its platform, the company delivers prescription and over-the-counter medications, lab testing, and ongoing clinical support to customers from home. It serves millions of consumers across the United States and is publicly traded on the NYSE under the ticker HIMS.
The company's offerings span several treatment areas, including hair loss, sexual health, weight management, mental health, and primary care. Its technical work covers telehealth, digital health platform development, e-commerce and direct-to-consumer operations, virtual care delivery, and lab testing integration.
Hims & Hers has raised over $200 million in funding and has been characterised as one of the fastest-growing direct-to-consumer brands in history. Its stated mission is to help people feel better through improved health, with an emphasis on normalising conversations about sensitive health topics and on making treatment more convenient, affordable, and accessible.
